Literature DB >> 13931274

Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.

E A LOELIGER, M J MATTERN, A S den BRABANDER.   

Abstract

Entities:  

Keywords:  ACENOCOUMAROL; BISHYDROXYCOUMARIN; COUMARINS; FACTOR IX; FACTOR VII; FACTOR X; PROTHROMBIN; WARFARIN

Mesh：

Substances：

Year:  1963        PMID： 13931274

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN： 0340-5338


× No keyword cloud information.
  6 in total

Review 1.  [THE STUART-PROWER FACTOR: ITS COAGULATION PHYSIOLOGY AND CLINICAL SIGNIFICANCE].

Authors:  V HIEMEYER; M H HOERDER
Journal:  Klin Wochenschr       Date:  1964-11-15

2.  [Changes of blood coagulation factors in long-term treatment with anticoagulants and in liver cirrhosis].

Authors:  L Nowicki; K W Schneider; M Reimers
Journal:  Blut       Date:  1966-04

3.  Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques.

Authors:  A Girolami; A Brunetti; G Bareggi
Journal:  Blut       Date:  1972-08

4.  [On the problem of hemostyptic effect of estriolsuccinate within the scope of anticoagulant therapy using coumarin derivatives].

Authors:  E Halberstadt; E Hentschel
Journal:  Arch Gynakol       Date:  1968

5.  Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.

Authors:  A Zivelin; L V Rao; S I Rapaport
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

6.  Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man.

Authors:  S Toon; K J Hopkins; F M Garstang; M Rowland
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.